Rigel Pharmaceuticals

About:

Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.

Website: http://www.rigel.com

Twitter/X: RigelPharma

Top Investors: New Enterprise Associates, U.S. Department of Defense, Frazier Healthcare Partners, Alta Partners, MPM Capital

Description:

Rigel Pharmaceuticals, Inc. (Rigel), is a clinical-stage drug development company. The Company discovers and develops small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. The Company has product development programs in inflammatory/autoimmune diseases, such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.